{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sodium+Fluorescein&page=2", "query": { "intervention": "Sodium Fluorescein", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 95, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sodium+Fluorescein&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Sodium+Fluorescein&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T23:28:44.221Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02857374", "title": "Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stage IB Skin Melanoma", "Stage IIA Skin Melanoma", "Stage IIB Skin Melanoma", "Stage IIC Skin Melanoma", "Stage IIIA Skin Melanoma", "Stage IIIB Skin Melanoma", "Stage IIIC Skin Melanoma" ], "interventions": [ { "name": "Diagnostic Microscopy", "type": "PROCEDURE" }, { "name": "Fluorescein Sodium Injection", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Sentinel Lymph Node Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2016-11-03", "completion_date": "2022-06-13", "has_results": false, "last_update_posted_date": "2022-08-01", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02857374" }, { "nct_id": "NCT02478346", "title": "Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cerebrovascular Disorders", "Intracranial Neoplasms" ], "interventions": [ { "name": "Fluorescein Sodium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AdventHealth", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2015-05", "completion_date": "2019-04", "has_results": false, "last_update_posted_date": "2017-02-14", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02478346" }, { "nct_id": "NCT01778920", "title": "Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung and Pleural Malignancies", "Neoplasms", "Nodules", "Adenocarcinoma" ], "interventions": [ { "name": "EC17 imaging contrast agent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2012-04", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-05-17", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01778920" }, { "nct_id": "NCT03531294", "title": "Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Retinopathy" ], "interventions": [ { "name": "Aflibercept Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Greater Houston Retina Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2018-05-23", "completion_date": "2021-04-09", "has_results": false, "last_update_posted_date": "2021-05-21", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 2, "location_summary": "Houston, Texas • The Woodlands, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03531294" }, { "nct_id": "NCT01471054", "title": "Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Macular Edema", "Cystoid Macular Edema", "Uveal Melanoma", "Radiation Maculopathy", "Radiation Retinopathy" ], "interventions": [ { "name": "Ozurdex", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arman Mashayekhi", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2014-04", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2019-09-03", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01471054" }, { "nct_id": "NCT04334707", "title": "Kidney Precision Medicine Project", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Kidney Failure", "Acute Kidney Insufficiency", "Acute Renal Failure", "Acute Renal Injury", "Acute Renal Insufficiency", "Kidney Failure, Acute", "Kidney Insufficiency, Acute", "Renal Failure, Acute", "Renal Insufficiency, Acute", "Chronic Kidney Diseases", "Chronic Kidney Insufficiency", "Chronic Renal Diseases", "Chronic Renal Insufficiency", "Kidney Insufficiency, Chronic", "Type 1 Diabetes (T1D)" ], "interventions": [ { "name": "Kidney Biopsy", "type": "PROCEDURE" }, { "name": "MRI", "type": "OTHER" }, { "name": "Retina Scan", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2019-09-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 13, "location_summary": "Tucson, Arizona • New Haven, Connecticut • Chicago, Illinois + 9 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04334707" }, { "nct_id": "NCT03297489", "title": "Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Fallopian Tube Carcinoma", "Primary Peritoneal Carcinoma", "Stage I Ovarian Cancer", "Stage IA Ovarian Cancer", "Stage IB Ovarian Cancer", "Stage IC Ovarian Cancer", "Stage II Ovarian Cancer", "Stage IIA Ovarian Cancer", "Stage IIB Ovarian Cancer", "Stage IIC Ovarian Cancer", "Stage III Ovarian Cancer", "Stage IIIA Ovarian Cancer", "Stage IIIB Ovarian Cancer", "Stage IIIC Ovarian Cancer", "Stage IV Ovarian Cancer" ], "interventions": [ { "name": "Diagnostic Microscopy", "type": "PROCEDURE" }, { "name": "Fluorescein Sodium Injection", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 19, "start_date": "2017-11-06", "completion_date": "2021-02-15", "has_results": false, "last_update_posted_date": "2021-10-06", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03297489" }, { "nct_id": "NCT02540135", "title": "Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "High Grade Malignant Neoplasm", "Glioblastoma Multiforme", "Anaplastic Astrocytoma" ], "interventions": [ { "name": "fluorescein", "type": "OTHER" }, { "name": "intraoperative MRI", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2015-03-01", "completion_date": "2018-07-18", "has_results": false, "last_update_posted_date": "2018-07-20", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02540135" }, { "nct_id": "NCT02028325", "title": "Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Adult Intracranial Neoplasm", "Vascular: Intracranial" ], "interventions": [ { "name": "Fluorescein Sodium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 136, "start_date": "2013-12", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2016-11-08", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 2, "location_summary": "Indianapolis, Indiana • Norfolk, Virginia", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02028325" }, { "nct_id": "NCT02691923", "title": "Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Cancer" ], "interventions": [ { "name": "Fluorescein", "type": "DRUG" }, { "name": "Fluorescein + ALA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David W. Roberts", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 30, "start_date": "2016-03", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-03T23:28:44.221Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT02691923" } ] }